Treatment of severe leukopenia with RHG-CSF in systemic lupus erythematosus treated with cyclophosphamide

Nephron

Volumn 73, Issue 4, 1996, Pages 715-

  Ruiz Valverde, M P ^a   Segarra, A ^a   Tovar, J L ^a   Ribera, R ^a   Piera, L ^a  

^a HOSPITAL GENERAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTRIAXONE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN;

ADOLESCENT; CASE REPORT; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOPENIA; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0029761153     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189170     Document Type: Article

References (5)

1. Licschke GJ. Burguess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Therapeutic applications. N Engl J Med 1992:327:99-106.
2. Schur PH: Clinical features of systemic lupus erythematosus: in Kelley WN. Harris ED Jr. Ruddy S (eds): Textbook of Rheumatology, ed 3. Philadelphia. Saunders. 1989.
3. Haskell CM: Principles and practice of cancer chemotherapy; in Haskell ChM (ed): Cancer Treatment, ed 3. Philadelphia. Saunders, 1990.
4. Groopman JE. Molina JM. Seaddcn DT: Hematopoietic Growth Factors. N Engl J Med 1989;321:1449-1459.
5. Teske E, Harten P. Schrocder JO. Euler HH: G-CSF following pulse cyclophosphamide in SLE. Arthritis Rheum 1992;35(suppl 9).